InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. A protein folding prediction in response to a small molecule generated by AlphaFold 3. “The response to ...

Google DeepMind cofounder and CEO Demis Hassabis and John Jumper, a senior researcher at the company, shared the 2024 Nobel Prize for Chemistry for their work on AlphaFold, an AI model that predicts ...

Mapping proteins unlocks clues to preventing and treating illnesses. Here’s how DeepMind’s AlphaFold is accelerating this research exponentially.

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More A trio of scientists consisting of Demis Hassabis, co-founder and CEO of ...

Most of the activities that go on inside cells—the activities that keep us living, breathing, thinking animals—are handled by proteins. They allow cells to communicate with each other, run a cell’s ...

When John Jumper got the call earlier this month from the Royal Swedish Academy of Sciences that he was winning the Nobel Prize, he almost didn’t answer. The director of Google DeepMind, the tech ...

Wednesday’s Nobel Prize in chemistry is an incredible vote of confidence in the potential for artificial intelligence to transform the way medicines are invented by using AI to illuminate and ...

AI begins transforming precision oncology, speeding drug target discovery with AlphaFold and cutting clinical trial paperwork from months to days. Chadi Nabhan, MD, MBA, FACP, hematologist-oncologist ...

The CEO of DeepMind has forecasted a fantastic shift in science: the rise of “digital biology.” This emerging discipline, powered by artificial intelligence (AI), is poised to redefine how we approach ...

While many businesses continue to seek AI’s killer app, biochemists have already found it. That application is protein folding. This week marks the five-year anniversary of the debut of Alpha Fold 2, ...